Data from the Hong Kong Stock Exchange shows that on July 24, The Capital Group Companies, Inc. increased its holdings in HENGRUI PHARMA (01276) by 752,200 shares.

The shares were acquired at an average price of HK$56.7648 each, resulting in a total transaction value of approximately HK$42.6985 million.

Following this purchase, the investment firm's total shareholding in Hengrui Pharma now stands at around 23.6978 million shares, representing a 9.18% stake in the company.